RT Journal Article
SR Electronic
T1 Evaluate the timing of resumption of business for the states of New York, New Jersey and California via a pre-symptomatic and asymptomatic transmission model of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.16.20103747
DO 10.1101/2020.05.16.20103747
A1 Tian, Ting
A1 Tan, Jianbin
A1 Jiang, Yukang
A1 Wang, Xueqin
A1 Zhang, Heping
YR 2020
UL http://medrxiv.org/content/early/2020/05/20/2020.05.16.20103747.abstract
AB The United States has the highest numbers of confirmed cases and death of COVID–19, where confirmed cases took up nearly half in the hot spot states of New York, New Jersey and California1,2. The workforce in these states was required to work from home except for essential services to minimize the risk of the spread of COVID–19. Premature reopening of economy will lead to broader spread of COVID–19, while the opposite situation would cause greater loss of economy. We proposed an epidemic compartmental model in considering the pre-symptomatic transmission and asymptomatic transmission3 of COVID–19, to estimate the numbers of unidentified infected cases and simulate the possible outcomes of resumption of economy at different forthcoming Mondays. The states of New York and New Jersey were not recommended to reopen the economy before May 18 since it may increase 22.44% and 60.18% for the numbers of cumulative confirmed cases if the second wave of the infection would happen, respectively. While that may be feasible for California to reopen business on May 11 if appropriate control measures for prevention of the second wave of the infection are implemented, because of the less benefit for delaying reopening the economy and the relatively smaller magnitude of Outbreak of COVID–19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partly supported by the National Key Research and Development Program of China (Grant No. 2018YFC1315400), the National Natural Science Foundation of China (Grant No. 11771462; Grant No. 71991474), the Key Research and Development Program of Guangdong, China (Grant No. 2019B020228001) and the Fundamental Research Funds for the Central Universities (19lgpy236).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDaily reported confirmed cases of COVID-19 from March 13, 2020 to May 4, 2020 for three states of New York, New Jersey and California from the website "https://covid-19.direct/state". All data are publicly available. https://covid-19.direct/state